Model B. The melatonin-produced increase in extracellular dopamine concentration in the striatum is prevented by the CYP2D inhibitor propafenone in pargyline-pretreated.

Slides:



Advertisements
Similar presentations
PI 3-kinase inhibition has no effect on ANG II induced extracellular recognition kinase (ERK) 1/2 activation. PI 3-kinase inhibition has no effect on ANG.
Advertisements

Fig. 1 Experimental design
From: Nerve Injury-related Autoimmunity Activation Leads to Chronic Inflammation and Chronic Neuropathic Pain Anesthes. 2013;118(2): doi: /ALN.0b013e31827d4b82.
Comparison of the model incorporating daily dose to that incorporating Cmax. Comparison of the model incorporating daily dose to that incorporating Cmax.
Effects of cytokines on P450 mRNA expression in human hepatocytes.
Downregulation of TRPC6 expression by sildenafil leads to reduced TRPC6–mediated Ca2+ influx into the podocyte. Downregulation of TRPC6 expression by sildenafil.
Evaluation of models incorporating the base covariates.
Representative radio-HPLC chromatograms for individual pooled methanolic fecal extracts for periods of maximum recovery of radioactivity after dosing of.
HPLC tracings of resveratrol (RV) and its major sulfate conjugates M4/M5 in the plasma from three subjects. HPLC tracings of resveratrol (RV) and its major.
Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: a microdialysis study  Y.U. Adachi,
Total ion current-EMS chromatograms of SB939 and its metabolites after incubation in liver microsomal fractions for 60 min at a concentration of 50 μM.
Structure of solid lipid nanoparticles (SLNs).
The three primary ADC components that determine which cells are targeted (antibody), how the drug is released (linker/trigger), and the mechanism of action.
Pathogenic potential of naïve Helicobacter-reactive CT6 cells in lymphopenic mice. Pathogenic potential of naïve Helicobacter-reactive CT6 cells in lymphopenic.
Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.
Choice of the study design (superiority vs non-inferiority design) for postregistration trials comparing different treatments for the same therapeutic.
Cytotoxic activities of polymer micelles containing CFZ in H460 (A) and select micelle formulations in RPMI-8226 (B) cell lines. Cytotoxic activities of.
Cytotoxic effects of PM1 and PM2 empty particle controls and coincubation of CFZ with empty particles tested in H460 (A) and RPMI-8226 (B) cells. Cytotoxic.
Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP,
The additive model assumes unspecific effects of equal size in both the placebo and drug arm or groups of studies or experiments. The additive model assumes.
Activation of PBN and CeA by illuminating the hindpaw after PNI
Halothane enhances dopamine metabolism at presynaptic sites in a calcium- independent manner in rat striatum  Y.U. Adachi, M. Satomoto, H. Higuchi, K.
Effects of inhibitors of drug efflux pumps on the penetration of antibiotics into the central nervous system. Effects of inhibitors of drug efflux pumps.
Volume 60, Issue 4, Pages (October 2001)
Comparison of the observed and calculated CLR values of taurine and GCDCA-S. Comparison of the observed and calculated CLR values of taurine and GCDCA-S.
WD confers vulnerability to OFT anxiety-like behaviors following traumatic stress exposure. WD confers vulnerability to OFT anxiety-like behaviors following.
Lauren Brash et al. BTS 2018;3:
(A) Illustration depicting two types of pharmacokinetic instability of an ADC. Conjugating an antibody with drug can accelerate its clearance (green versus.
Pharmacologic inhibitors of PI3Kγ suppress PDAC growth and metastasis.
Tukey boxplots overlaid on data points from objective and subjective measures, displaying results from study 1. Tukey boxplots overlaid on data points.
The up-regulation of Galnt3 by Pi requires activation of the ERK pathway and induction of Egr1 and Etv5. The up-regulation of Galnt3 by Pi requires activation.
Effects of gemfibrozil on the exposure (area under the plasma drug concentration-time curve) to different CYP2C8 substrate drugs. Effects of gemfibrozil.
Schematic illustration of the interaction between CYP2C8 and its glucuronide substrates. Schematic illustration of the interaction between CYP2C8 and its.
Simpson's biplane ejection fraction (A), and two-dimensional speckle-tracking global longitudinal strain (B) in patients receiving clozapine treatment,
Results of thermogravimetric measurements of peptide ghrelin antagonist (GhA) and loaded into PSi microparticles. Results of thermogravimetric measurements.
Effect of insulin on hepcidin expression in HepG2 cells.
Fig. 1 KCC2 down-regulation is prevented in sortilin-deficient mice.
Glucose tolerance in WT and TRPM2-KO mice.
Dose-normalized plasma concentration-time curves of a mAb following subcutaneous (SC) and intravenous (IV) administration to cynomolgus monkeys (mean ±
Arterial and portal plasma glucagon levels and the portal-arterial (P-A) glucagon gradient in the control period (−40 to 0 min) and after administration.
The portal-arterial (P-A) insulin gradient and arterial plasma c-peptide levels in the control period (−40 to 0 min) and after administration of the glycogen.
Electrically evoked dopamine transients and regulation of dopamine signals by firing frequency in wild-type and triple-synuclein-null mutant mice measured.
Half-life of removal from subcutaneous administration site after subcutaneous administration of fluorescence-labeled VEGF-C156S, ovalbumin (OVA), bovine.
Fraction of dose (mean, n = 3–4) recovered in peripheral lymph following subcutaneous administration to sheep for a series of small molecular compounds.
Stereoimage of three independent docking simulations of the interaction between clopidogrel acyl 1-β-d-glucuronide and the active site of CYP2C8. Stereoimage.
Interaction between reboxetine and ADRA2B genotype influences post-treatment symptoms of irritability, anxiety, and dizziness. Interaction between reboxetine.
Chronic SSRI treatment rescued lOFC hyperactivity in QNP-treated mice.
Interference of Kv4 in dorsal neurons (DN1s) does not significantly regulate sleep onset. Interference of Kv4 in dorsal neurons (DN1s) does not significantly.
Effect of PPARγ agonist on Aβ phagocytosis in primary microglia.
CBD elevates AEA levels in poly-(I:C)–stimulated HaCaT cells after 6 hours. CBD elevates AEA levels in poly-(I:C)–stimulated HaCaT cells after 6 hours.
CBD and other phytocannabinoids are not cytotoxic in HaCaT cells.
The dopamine (DA) response to cocaine infusion in the NAc in constitutive p11 KO mice is restored by nicotinic or muscarinic receptor stimulation in the.
Cue-evoked dopamine release dynamics in the NAc shell and core.
NicA2-J1 prevents nicotine addiction–like behavior during withdrawal
Unbound drug concentrations in plasma (dotted) and brain ISF (solid, calculated from recovery and dialysate concentration) following repeated subcutaneous.
AEA and URB597 reduce MCP-2, IL-6, and IL-8 levels in poly-(I:C)–stimulated HaCaT cells after 6 hours. AEA and URB597 reduce MCP-2, IL-6, and IL-8 levels.
Involvement of cys298 in the interaction of PGA1 with AKR1B1.
Differentiation of common pediatric brain tumors by quantitative 1H-MR spectroscopy. Differentiation of common pediatric brain tumors by quantitative 1H-MR.
Effects of d-xylose or sucralose (control) with or without sitagliptin on gastric emptying (half-emptying time [T50]) (n = 12). Effects of d-xylose or.
Activation and desensitization of the α7 nAChRs.
The effect of a change in the expression level of the receptor and the binding affinity on the subcutaneous bioavailability of mAbs. The effect of a change.
Linear regressions for treatment numbers and SDPPP indices in various twitch forces. ETOIMS (Electrical Twitch-Obtaining Intramuscular Stimulation); SDPPP.
FcRγ signaling regulates BTK activation and mediates PDAC growth.
Three-day biodistribution of 125I-labeled chTNT-3 administered at (A) 1, 2, or 3 days after pretreatment with VP-16 (30 mg/kg) in MAD109 bearing BALB/c.
Average trastuzumab serum concentrations in female minipigs following single subcutaneous administration of trastuzumab in formulations without and with.
Allometric relationship between the lymph flow in the thoracic duct and species body weight. Allometric relationship between the lymph flow in the thoracic.
15d-PGJ2 and 15d-PGJ2-G both stimulate nuclear translocation of Nrf2 in HUVEC endogenously expressing MAGL. (A) Competitive APBB of HUVEC lysates unveiling.
Fig. 6 NicA2-J1 prevents nicotine- and stress-induced reinstatement after extinguished nicotine intake. NicA2-J1 prevents nicotine- and stress-induced.
Fig. 2. Col IV–Ac2-26 NPs increase subendothelial collagen in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26 NPs increase subendothelial.
Comparison of sympathetic activity, endothelial function and baroreflex sensitivity between differing metabolic risk categories (n=54). Comparison of sympathetic.
Presentation transcript:

Model B. The melatonin-produced increase in extracellular dopamine concentration in the striatum is prevented by the CYP2D inhibitor propafenone in pargyline-pretreated rats. Model B. The melatonin-produced increase in extracellular dopamine concentration in the striatum is prevented by the CYP2D inhibitor propafenone in pargyline-pretreated rats. Drugs were given as indicated with an arrow. The obtained values are the mean ± S.E.M. (n = 5–8). A repeated-measures analysis of variance showed effect of treatment (F = 5.25, P = 0), effect of time (F = 11.27, P = 0), and interaction between both factors (F = 55.27, P = 0). #P < 0.001 (P = 0.00014; versus control); *P < 0.001 (P = 0, 00014; versus pargyline); ^P < 0.001 (P = 0.00014; versus pargyline plus melatonin); !P < 0.1 (P = 0.053; versus pargyline plus propafenone) (repeated-measures analysis of variance and Tukey’s post hoc test). MEL, melatonin; PARG, pargyline; PFN, propafenone. Anna Haduch et al. Drug Metab Dispos 2016;44:445-452 Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics